GlassScriptPhysician profile
Amit Nanavati
NPI 1932373479
$17,382.30
in general payments reported to CMS, 2019-2025
42 companies · $960 in 2025
The $960 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,630 · 2020: $635 · 2021: $1,168 · 2022: $2,446 · 2023: $1,409 · 2024: $1,135 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,504.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $8,514.64 | 2019-2020 | |
| Penumbra, INC. | $1,229.30 | 2019-2025 | Ruby Coil |
| Medtronic, INC. | $836.50 | 2021-2025 | Telescope, Resolute Onyx, Abre |
| Janssen Pharmaceuticals, INC | $734.21 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $651.27 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $620.07 | 2019-2025 | |
| Amgen INC. | $529.91 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $508.66 | 2021-2025 | Verquvo, Capvaxive |
| Cordis US Corp. | $493.19 | 2022-2024 | Zephyr, Mynx Control, Radial 360 |
| Cvrx, INC. | $485.43 | 2019-2023 | Barostim Neo System |
| Esperion Therapeutics, INC. | $350.99 | 2021-2025 | Nexletol |
| Boston Scientific Corporation | $313.91 | 2019-2024 | Versacross Access Solution, Watchman Access System, Eluvia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.93 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $235.72 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.25 | 2019-2025 | Lifevest |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Nanavati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.